Answers are grounded in this paper and cite their sources.
Reconstituted high-density lipoprotein (rHDL) particles adopt distinct structural states, yet how these states influence receptor recognition remains incompletely understood. Here, we compared the structural features of discoidal rHDL and LCAT-remodeled spherical-like rHDL model particles and evaluated their interactions with scavenger receptor class B type I (SR-BI). Recombinant apolipoprotein A-I (ApoA-I) was expressed and used to assemble discoidal rHDL, which was subsequently converted into spherical-like rHDL through lecithin-cholesterol acyltransferase (LCAT)-mediated remodeling. Agarose gel electrophoresis, transmission electron microscopy, and 1H–15N HSQC NMR spectroscopy confirmed that the two rHDL species differed in electrophoretic mobility, morphology, size distribution, and ApoA-I spectral properties. In particular, ApoA-I in discoidal rHDL exhibited greater NMR visibility than in LCAT-remodeled spherical-like rHDL, consistent with distinct conformational and dynamic states. Biolayer interferometry further showed that LCAT-remodeled spherical-like rHDL model particles bound SR-BI with substantially higher apparent affinity than discoidal rHDL. Together, these findings demonstrate that the structural state of rHDL strongly influences its interaction with SR-BI and support a model in which the LCAT-remodeled structural transition of rHDL is accompanied by ApoA-I reorganization that favors receptor binding. This study provides mechanistic insight into how structural changes in model rHDL particles modulate receptor engagement.
No takes yet. Share an insight, caveat, or question.
Wang et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: